Package 71610-774-80

{"route": ["ORAL"], "spl_id": "edf166e7-bcf0-4bda-97ea-d9b82140aab3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["8d80f882-1887-4d73-b09f-e98fd7ef2acb"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (71610-774-53)", "package_ndc": "71610-774-53", "marketing_start_date": "20240122"}, {"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (71610-774-70)", "package_ndc": "71610-774-70", "marketing_start_date": "20240125"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (71610-774-80)", "package_ndc": "71610-774-80", "marketing_start_date": "20240125"}, {"sample": false, "description": "360 TABLET, FILM COATED in 1 BOTTLE (71610-774-94)", "package_ndc": "71610-774-94", "marketing_start_date": "20240125"}], "brand_name": "Bupropion Hydrochloride", "product_id": "71610-774_edf166e7-bcf0-4bda-97ea-d9b82140aab3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-774", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20060117", "listing_expiration_date": "20261231"}